Trial Participation May Not Improve Cancer Outcomes in Low Income Areas
Researchers demonstrated the significance of access to supportive and posttrial care as it relates to cancer survival among clinical trial participants.
Urology News
UROLOGY NEWS
FDA Approves Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
In a phase 3 trial that included 1052 men with metastatic castration-sensitive prostate cancer, apalutamide plus androgen deprivation therapy (ADT) was associated with a 33% decreased risk of death compared with those who received placebo plus ADT.
Adding Carboplatin to Cabazitaxel May Slow mCRPC Progression
In a phase 2 trial of men with metastatic castration-resistant prostate cancer, cabazitaxel plus carboplatin significantly prolonged progression-free survival compared with cabazitaxel alone.
Sipuleucel-T Efficacy, Safety in mCRPC Evaluated in Real World Study
The median time from first infusion of sipuleucel-T to death from prostate cancer was 42.7 months.
Preoperative mpMRI Possibly Beneficial in High-Risk Prostate Cancer
Study suggests that prostate mpMRI prior to radical prostatectomy for high-risk prostate cancer could lead to changes in surgical planning that may potentially affect patient outcomes.
Microbiome Analysis May Be a Feasible Diagnostic Test for Prostate Cancer
The microbiome could have a role in the diagnosis of PrCa.
Data Support Confirmatory MRI-Guided Prostate Biopsy Before AS
Confirmatory biopsy with MRI guidance provides a more accurate risk assessment than a conventional transrectal ultrasound confirmatory biopsy, according to researchers.
Can Testosterone Therapy Lower Prostate Cancer Risk?
In a study, investigators observed a reduced probability of prostate cancer in nondiabetic men with greater use of testosterone therapy.
Mushrooms May Lower Prostate Cancer Risk
In a study, Japanese men who ate mushrooms each week had lower risk for prostate cancer.
Pre-RARP Bladder Outlet Obstruction Predicts Decline in Lower Urinary Tract Function
Men who have bladder outlet obstruction (BOO) prior to robotic-assisted radical prostatectomy experience significant worsening of lower urinary tract function compared with men without BOO, a study found.
Want to read more?
Please login or register first to view this content.
Next post in Urology
